🔎 Trials Near Me

Beranda › Kanker Paru Non-Sel Kecil › Illinois › Peoria

Uji klinis Kanker Paru Non-Sel Kecil di Peoria, IL

21 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Peoria (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Menerima pesertaFase 3
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • Illinois CancerCare-Canton, Canton · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • Illinois CancerCare-Canton, Canton · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Menerima pesertaFase 2
  • Illinois CancerCare-Peoria, Peoria
  • OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria
  • OSF Saint Francis Medical Center, Peoria
  • dan 3 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07293247

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Menerima pesertaFase 2/3
  • OSF Saint Francis Medical Center, Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07365319

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Menerima pesertaFase 3
  • Illinois Cancer Care ( Site 7000), Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07513376

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Menerima pesertaFase 3
  • Illinois Cancer Care, Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07361497

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Menerima pesertaFase 3
  • Illinois Cancer Care, Peoria
  • Illinois CancerCare- Pekin, Pekin · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Illinois CancerCare, P.C., Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07222566

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Menerima pesertaFase 2
  • Illinois CancerCare-Peoria, Peoria
  • Methodist Medical Center of Illinois, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT03191149

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • OSF Saint Francis Medical Center, Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06890598

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Menerima pesertaFase 1
  • OSF Health Care, Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07140016

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Menerima pesertaFase 1
  • OSF Saint Francis Medical Center, Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06343402

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

Menerima pesertaFase 1
  • OSF Healthcare System; Saint Francis Medical Center, Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07027514

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • St. Francis Medical Center (OSF Healthcare), Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07444814

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • Illinois CancerCare-Canton, Canton · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Menerima pesertaFase 1
  • OSF Healthcare Cancer Institute, Peoria
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT06917079

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • Illinois CancerCare-Canton, Canton · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • Illinois CancerCare-Canton, Canton · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • Illinois CancerCare-Canton, Canton · 25 mi jauhnya
18 Minutes · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi jauhnya
  • Illinois CancerCare-Canton, Canton · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

Uji klinis Kanker Paru Non-Sel Kecil di kota lain

Studi lain di Peoria

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.